Nevertheless, expression of immunoactive IFN-α and T-cell chemokines, IP-10 and Gro-α selectively in the tumor (Figure 4) should drive the immune response specifically against GBM, reducing potential toxic effects on surrounding brain tissue. This evidence concerns the gene CXCL10 and neoplasm.